US20040054582A1 - Technical task performance techniques - Google Patents
Technical task performance techniques Download PDFInfo
- Publication number
- US20040054582A1 US20040054582A1 US10/415,760 US41576003A US2004054582A1 US 20040054582 A1 US20040054582 A1 US 20040054582A1 US 41576003 A US41576003 A US 41576003A US 2004054582 A1 US2004054582 A1 US 2004054582A1
- Authority
- US
- United States
- Prior art keywords
- parties
- chemical
- drug
- technical task
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 78
- 150000001875 compounds Chemical class 0.000 claims abstract description 37
- 239000000126 substance Substances 0.000 claims abstract description 28
- 238000011161 development Methods 0.000 claims abstract description 17
- 238000004458 analytical method Methods 0.000 claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 33
- 229940079593 drug Drugs 0.000 claims description 33
- 238000003786 synthesis reaction Methods 0.000 claims description 15
- 238000012360 testing method Methods 0.000 claims description 15
- 230000015572 biosynthetic process Effects 0.000 claims description 13
- 230000008569 process Effects 0.000 claims description 12
- 238000003556 assay Methods 0.000 claims description 9
- 238000011156 evaluation Methods 0.000 claims description 9
- 230000000144 pharmacologic effect Effects 0.000 claims description 6
- 230000004044 response Effects 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 238000004611 spectroscopical analysis Methods 0.000 claims description 3
- 238000012356 Product development Methods 0.000 claims description 2
- 238000010171 animal model Methods 0.000 claims description 2
- 238000009509 drug development Methods 0.000 claims description 2
- 239000002207 metabolite Substances 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 claims description 2
- 238000005457 optimization Methods 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 238000011160 research Methods 0.000 claims description 2
- 231100000027 toxicology Toxicity 0.000 claims description 2
- 239000013583 drug formulation Substances 0.000 claims 3
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 238000013461 design Methods 0.000 claims 1
- 238000002474 experimental method Methods 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 230000018109 developmental process Effects 0.000 description 15
- 238000012216 screening Methods 0.000 description 6
- 238000011170 pharmaceutical development Methods 0.000 description 5
- 238000004891 communication Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002547 new drug Substances 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000009533 lab test Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000005556 structure-activity relationship Methods 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000013461 intermediate chemical Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- -1 procedure Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 239000002887 superconductor Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/10—Office automation; Time management
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/06—Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
- G06Q10/063—Operations research, analysis or management
- G06Q10/0639—Performance analysis of employees; Performance analysis of enterprise or organisation operations
- G06Q10/06398—Performance of employee with respect to a job function
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/02—Marketing; Price estimation or determination; Fundraising
- G06Q30/0207—Discounts or incentives, e.g. coupons or rebates
- G06Q30/0239—Online discounts or incentives
Definitions
- the present invention relates to the performance of technical tasks, and more particularly but not exclusively, relates to strategies to more effectively perform tasks in the area of pharmaceutical development.
- the process of providing a new drug includes many steps that may involve substantial amounts of time, resources, and expenses. In its earliest stages, this process typically includes the discovery of a molecule with one or more potentially beneficial therapeutic indications. Following discovery, laboratory testing of the potential drug is usually conducted to determine suitability as a candidate for formal regulatory approval. Formal requirements for drug approval typically include verifying synthesis routes for producing the new drug, conducting clinical trials with the drug to establish safety and efficiency, making regulatory submissions, and finally preparing the drug for market. Each of these steps requires specific expertise, and the time and expense involved can be great. Development of drugs can therefore be a very expensive, high-risk business.
- One embodiment of the present invention includes a unique technical task performance technique.
- Other embodiments include unique systems and methods directed to the performance of technical tasks.
- Another embodiment of the present invention includes providing a description of a technical task to a number of parties and offering a bounty to any party that performs the task in accordance with certain requirements. Performance by at least one of the parties is evaluated and the bounty is awarded to one of the parties that performs the task in compliance with the requirements.
- a further embodiment of the present invention includes providing an offer to reward any of several parties for development of an acceptable chemical synthesis procedure.
- a submission is evaluated that relates to a procedure developed in response to this offer for each of a number of the parties.
- One of the parties is determined to have developed the acceptable synthesis procedure and is rewarded.
- this procedure is directed to the more economical synthesis of a drug chemical.
- Yet a further embodiment of the present invention includes publishing a description with a reward offer for acceptable development of a technical task for a chemical compound and providing an amount of the chemical compound to each of a number of parties responsive to the offer. Performance of the technical task by at least one of the parties is evaluated and one of the parties is rewarded in accordance with the offer.
- Still a further embodiment of the present invention includes publishing a description of a technical task to a number of parties.
- the description offers a reward contingent upon the performance of the technical task by any of the parties in accordance with a predefined requirement.
- One of the parties is determined to perform the task in accordance with the predefined requirement and the reward is provided to that party.
- the publication can take place over a publicly accessible computer network, such as the internet.
- the technical task can be directed to technical research, laboratory testing, product discovery, product development, and/or product manufacture, just to name a few.
- one object of the present invention is to provide a unique technical task performance technique.
- Another object is to provide a unique system or method directed to technical task performance.
- FIG. 1 is a diagrammatic view of a system of one embodiment of the present invention.
- FIGS. 2A and 2B collectively depict a flowchart of one routine for operating the system of FIG. 1.
- FIG. 3 is an example of a technical task description presented in accordance with the routine of FIGS. 2A and 2B.
- One embodiment of the present invention is a method to motivate technical task performance by offering a reward contingent on development of the process in accordance with one or more acceptance criteria. This method is especially significant in the area of drug development tasks such as synthesis procedures, assays, formulations, and the like.
- a method includes providing a description including a reward offer for acceptable performance of a technical task involving a chemical compound, and providing an amount of the chemical compound to each of several parties responsive to the reward offer.
- Such methods provide an incentive for a greater number of parties to perform specified technical tasks than can ordinarily be economically justified using existing schemes. Further, this strategy has the potential to result in a more diverse array of technical task performance approaches than existing schemes; and thereby enrich the number of options from which to choose.
- FIG. 1 illustrates system 20 of one-embodiment of the present invention.
- System 20 includes computer network 22 that preferably includes a publicly accessible, Wide Area Network (WAN), such as the Internet.
- Computer network 22 communicatively links a number of potential developer sites or parties 24 and bounty offering/posting site 26 .
- Developer sites 24 each represent one or more companies, universities, individuals, or other entities that might have an interest in performing one or more technical tasks or services. While four developer sites 24 are illustrated, for the sake of clarity it should be understood that more or fewer development sites 24 could be coupled to computer network 22 in the manner illustrated. Typically, many more prospective developer sites 24 would be coupled to computer network 22 for an embodiment of the present invention that includes the Internet.
- Developer sites 24 each include one or more computers or other interface devices 28 to communicate over computer network 22 .
- Offering/posting site 26 includes at least one computer server 30 for publishing one or more descriptions 32 that each relate to a technical task, a few of which are schematically represented in FIG. 1 as descriptions 32 a , 32 b , and 32 c .
- Offering/posting site 26 further includes an input (I/P) device 34 and an output (O/P) device 36 each operatively coupled to server 30 .
- I/P input
- O/P output
- Input device 34 may be a mouse, keyboard, trackball, voice recognition arrangement, a combination of these, or a different configuration as would occur those skilled in the art for receiving input from a server operator.
- Output device 36 can include a visual display, aural output arrangement, a printer, a combination of these, or a different configuration as would occur to those skilled in the art to provide output from server 30 to the server operator.
- Offering/posting site 26 also has access to one or more sources 40 of chemical compounds that are schematically represented in FIG. 1. These chemical compounds are involved in the pharmaceutical development(s) to which one or more of the technical task descriptions 32 are directed.
- FIG. 1 also schematically depicts chemical analysis equipment 50 such as a mass spectrometer, nuclear magnetic resonance spectrometer, infra-red spectrometer, ultra-violet spectrometer, gas chromatograph device, and/or one or more other chemical analysis devices that can be used to evaluate various chemically related technical tasks. Any of developer sites 24 may likewise include such equipment, but are not shown as such to preserve clarity.
- server 30 is preferably configured to provide a website upon which descriptions 32 are each posted as one or more web pages that can be accessed using a standard web browser program.
- devices 28 of sites 24 could be used in conjunction with a web browser to access this form of descriptions 32 .
- descriptions 32 can be made available to public in a totally unrestricted manner or restricted in part or in whole to selected individuals or groups by requiring entry of a password, decryption key, or the like.
- access can be conditioned on acceptance of a confidentiality agreement by the inquiring party.
- descriptions 32 can be provided using a different media selected to reach potential process developers. Indeed, in one alternative embodiment, a computer network is not utilized.
- routine 120 begins in stage 122 with the identification of a technical task for which it is suitable to offer a reward contingent on meeting predetermined acceptance requirement(s).
- various so-called “wet lab” tasks might include providing: (a) a more economical procedure to synthesize the target drug chemical and/or an intermediate chemical compound; (b) one or more samples of new chemical structures for pharmacological testing; (c) an analysis procedure for assaying a new substance; (d) a formulation of a new molecule entity as a new potential drug product; (e) a procedure for constructing a new chemical library; (f) a toxicity study of a new potential drug substance; (g) an identification of one or more metabolites; (h) one more pharmacological screens to show drug activity; (i) one or more surrogate markets for a disease state (lab test to predict clinical results); (j) an animal model for a disease; and/or (k) a clinical or blood plasma assay of a drug under test, just to name a few.
- laboratory-oriented technical tasks might include providing: (a) a new way of integrating/connecting laboratory equipment; (b) a new toxicology prediction procedure; (c) a statistical optimization protocol for one or more laboratory experiments; and/or (d) a drug efficacy prediction tool/procedure for Structure-Activity Relationships (SARs).
- SARs Structure-Activity Relationships
- Description 32 preferably states the reward offer as a fixed monetary amount, a monetary amount that varies with indicated performance criteria, a portion of production sales, a combination of these, or in a different manner as would occur to those skilled in the art.
- an invitation to bid on the reward terms could be presented in description 32 .
- Description 32 can also set-forth the requirement or requirements from which to determine entitlement to the reward.
- Description 32 is made available via computer network 22 as one or more web pages.
- description 32 can be alternatively or additionally provided by video, telefax, hard copy, verbal form, and/or with a different communication technique known to those skilled in the art besides a computer network.
- conditional 126 is encountered that tests whether there is a party interested in description 32 as indicated by an email inquiry, or other form of communication. Such communication could be from any prospective developer site 24 via the corresponding device 28 , by telephone, telefax, or through different communication techniques as are known to those skilled in the art. If the test of conditional 126 is negative, route 120 loops back to conditional 126 until the test is affirmative. Once conditional 126 is affirmative, conditional 128 is encountered to test whether the interested party should be screened to determine suitability as a provider of the subject technical task. If a screen is applied, the affirmative branch of conditional 128 leads to stage 130 to perform the associated screening. Next, conditional 132 tests if screen 130 is passed by the interested party. If not, the interested party is informed of their ineligibility to participate in stage 133 , and routine 120 again loops back to conditional 126 .
- the screening process of routine 120 can be directed to any number of different criteria before an acceptable party can become a participant.
- this screening criteria may include verification that certain equipment and/or resources are available to the interested party.
- credentials of the interested party can be investigated through stage 130 .
- Screening stage 130 can be used to conduct a procedure to qualify the interested party for continued participation.
- stage 130 can include establishment of a confidentiality agreement between the interested party and the entity represented by site 26 to keep later revealed details confidential.
- the screening provided by conditionals 128 and 132 , and stages 130 and 133 can be optional or absent.
- routine 120 proceeds to stage 134 .
- stage 134 the interested party is provided a corresponding development kit that can include more detailed descriptive information, and/or a sample amount of one or more materials to which the corresponding technical task is directed.
- a sample of a drug chemical associated with the development could be provided.
- the provision of a development kit in stage 134 can be optional or even absent.
- description 32 a is further illustrated in FIG. 3.
- the corresponding technical task relates to synthesis of a schematically depicted chemical structure 132 in a manner acceptable for use as a human pharmaceutical with criteria including an overall cost goal and purity level as set forth in the first paragraph.
- the reward included in description 32 a has a cash component of $75,000 and a royalty stream component contingent upon use of the synthesis process developed. The royalty is capped at a maximum of $2,000,000 per year.
- routine 120 continues with evaluation subroutine 140 .
- Evaluation subroutine 140 starts with conditional 142 that tests whether results have been provided by a participating party in response to the corresponding description 32 of stage 124 .
- these results can include data provided by designated laboratory procedures and/or equipment.
- process evaluation subroutine 140 is directed to evaluating performance of the technical task of description 32 a .
- spectroscopic analysis of the output produced by the developed chemical synthesis procedure is to be submitted as part of the evaluation.
- Conditional 144 accordingly tests whether the spectral data indicates an acceptable process. If the spectrum is not acceptable, the unacceptable status is reported to the submitting participant in stage 154 and subroutine 140 loops back to conditional 142 .
- subroutine 140 proceeds to stage 146 to request a sample of a corresponding chemical compound produced by the participant as would be appropriate for the case of the new synthesis route development. For other types of technical tasks, a sample could be provided at the same time as spectral data is provided in stage 142 , or may not be included as part of the evaluation criteria at all. If a sample is submitted in response to stage 146 , its acceptability is then evaluated in accordance with conditional 148 using some or all of the associated chemical analysis equipment 50 as needed. In one embodiment relating to the description 32 a of FIG. 3, spectral analysis is conducted with this equipment to evaluate the sample, and/or one or more assays are performed. If the sample is unacceptable as tested by conditional 148 , this negative evaluation is reported in stage 154 and subroutine 140 loops back to conditional 142 . If the sample is acceptable, in stage 150 an attempt is made to replicate the process, as applicable.
- Conditional 152 tests whether the replication is acceptable. If the replication is unacceptable, subroutine 140 reports to the participant in stage 154 and returns to conditional 142 . If the submitted process is acceptably validated by the replication, subroutine 140 is exited and the reward is provided in stage 160 . Next, in stage 162 , the description is altered as appropriate to the circumstances. For example, it may be altered to indicate that the bounty has been claimed or otherwise modify the conditions under which participation is to continue.
- the reward may not be provided in stage 160 until an appropriate length of time passes, and/or until all known participants have been evaluated.
- the description may unconditionally provide the reward to the first party to meet the acceptance criteria, while in others it may be the best process among several participants that exceed predefined, minimum requirements. Indeed, in still other embodiments, one or more participants that meet the minimum acceptance criteria can be rewarded.
- the first five synthesis procedures that meet the target criteria are each provided a cash award of ten thousand dollars ($10,000), even if they are not used. It should be understood that routine 120 can be executed with system 20 for any of a number of different bounty descriptions 32 at the same time.
- evaluation routine 140 can be suitably adjusted.
- a given task may not produce a spectrum and/or sample - - - instead the evaluation is based on other quantitative and/or qualitative data as appropriate for the given task type.
- technical tasks directed to other developments/applications can be performed in accordance with the present invention.
- technical tasks can be bountied for providing/developing: (a) an electrical circuit designed to a designated specification; (b) an optical lens designed to a designated specification; (c) a polymer having specified properties; (d) a software program having specified performance parameters; (e) a superconductor with specified properties; and/or (f) such other material, procedure, product, system, or assembly as would occur to those skilled in the art.
Abstract
One form of the present invention includes a computer network, an input device, and a computer server. The computer server is coupled to the network and input device, and is programmed to present a publicly accessible description over the network. This description includes a reward offer contingent on acceptable development of a technical task. The computer server is responsive to input from the input device to alter the description when it is determined that the task has been acceptably performed. In a further form, the task involves production of a chemical compound sample and chemical analysis equipment is included to evaluate the sample.
Description
- The present invention relates to the performance of technical tasks, and more particularly but not exclusively, relates to strategies to more effectively perform tasks in the area of pharmaceutical development.
- The process of providing a new drug includes many steps that may involve substantial amounts of time, resources, and expenses. In its earliest stages, this process typically includes the discovery of a molecule with one or more potentially beneficial therapeutic indications. Following discovery, laboratory testing of the potential drug is usually conducted to determine suitability as a candidate for formal regulatory approval. Formal requirements for drug approval typically include verifying synthesis routes for producing the new drug, conducting clinical trials with the drug to establish safety and efficiency, making regulatory submissions, and finally preparing the drug for market. Each of these steps requires specific expertise, and the time and expense involved can be great. Development of drugs can therefore be a very expensive, high-risk business.
- From a business perspective, the success of a potential drug often depends on the identification of an economic route to synthesize it. Also, a successful outcome is frequently enhanced by developing or refining several other corresponding technical tasks, such as pharmacological assays, formulations, and the like. The rapid and efficient development of such tasks presents an ever-growing challenge as the desire to more rapidly bring new drugs to market increases.
- On occasion, drug developers will seek an outside consultant or developer having specific expertise in regard to a selected task. The business arrangement with the outside source is typically through a service and/or supply contract, partnership, or joint venture agreement. Indeed, various tasks may be outsourced to a number of different outside sources in this manner. Moreover, in an attempt to more rapidly develop a given task, a drug company might pay multiple independent parties to work towards the development of the same task. Ultimately, distributing developmental tasks in this manner would lead to the development and marketing of drugs that otherwise may not have been possible due to limited technical expertise or limited resources of a given company. Indeed, this kind of task distribution can be beneficial to developments in many other areas of technology, such as the material sciences, electronics, or optics, to name just a few.
- Unfortunately, the ability to increase the number of independent parties working on a given task or development is limited by the costs of such an endeavor. Thus, needs remain for techniques to enhance the performance of technical tasks by involving multiple parties in a unique way. The present invention involves methods and systems that satisfy these needs by providing a contingent reward or “bounty” to motivate acceptable technical task performance.
- One embodiment of the present invention includes a unique technical task performance technique. Other embodiments include unique systems and methods directed to the performance of technical tasks.
- Another embodiment of the present invention includes providing a description of a technical task to a number of parties and offering a bounty to any party that performs the task in accordance with certain requirements. Performance by at least one of the parties is evaluated and the bounty is awarded to one of the parties that performs the task in compliance with the requirements.
- A further embodiment of the present invention includes providing an offer to reward any of several parties for development of an acceptable chemical synthesis procedure. A submission is evaluated that relates to a procedure developed in response to this offer for each of a number of the parties. One of the parties is determined to have developed the acceptable synthesis procedure and is rewarded. In one form, this procedure is directed to the more economical synthesis of a drug chemical.
- Yet a further embodiment of the present invention includes publishing a description with a reward offer for acceptable development of a technical task for a chemical compound and providing an amount of the chemical compound to each of a number of parties responsive to the offer. Performance of the technical task by at least one of the parties is evaluated and one of the parties is rewarded in accordance with the offer.
- Still a further embodiment of the present invention includes publishing a description of a technical task to a number of parties. The description offers a reward contingent upon the performance of the technical task by any of the parties in accordance with a predefined requirement. One of the parties is determined to perform the task in accordance with the predefined requirement and the reward is provided to that party. The publication can take place over a publicly accessible computer network, such as the internet. Further, the technical task can be directed to technical research, laboratory testing, product discovery, product development, and/or product manufacture, just to name a few.
- Accordingly, one object of the present invention is to provide a unique technical task performance technique.
- Another object is to provide a unique system or method directed to technical task performance.
- Further objects, embodiments, forms, advantages, benefits, features, and aspects of the present invention shall become apparent from the description and drawings contained herein.
- FIG. 1 is a diagrammatic view of a system of one embodiment of the present invention.
- FIGS. 2A and 2B collectively depict a flowchart of one routine for operating the system of FIG. 1.
- FIG. 3 is an example of a technical task description presented in accordance with the routine of FIGS. 2A and 2B.
- While the present invention may be embodied in many different forms, for the purpose of promoting an understanding of the principles of the invention, reference will now be made to the embodiments illustrated in the drawings and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of the invention is thereby intended. Any alterations and further modifications in the described embodiments, and any further applications of the principles of the invention as described herein are contemplated as would normally occur to one skilled in the art to which the invention relates.
- One embodiment of the present invention is a method to motivate technical task performance by offering a reward contingent on development of the process in accordance with one or more acceptance criteria. This method is especially significant in the area of drug development tasks such as synthesis procedures, assays, formulations, and the like. In another embodiment, a method includes providing a description including a reward offer for acceptable performance of a technical task involving a chemical compound, and providing an amount of the chemical compound to each of several parties responsive to the reward offer. Such methods provide an incentive for a greater number of parties to perform specified technical tasks than can ordinarily be economically justified using existing schemes. Further, this strategy has the potential to result in a more diverse array of technical task performance approaches than existing schemes; and thereby enrich the number of options from which to choose.
- Still other embodiments include systems to implement such methods. For example, FIG. 1 illustrates
system 20 of one-embodiment of the present invention.System 20 includescomputer network 22 that preferably includes a publicly accessible, Wide Area Network (WAN), such as the Internet.Computer network 22 communicatively links a number of potential developer sites orparties 24 and bounty offering/postingsite 26.Developer sites 24 each represent one or more companies, universities, individuals, or other entities that might have an interest in performing one or more technical tasks or services. While fourdeveloper sites 24 are illustrated, for the sake of clarity it should be understood that more orfewer development sites 24 could be coupled tocomputer network 22 in the manner illustrated. Typically, many moreprospective developer sites 24 would be coupled tocomputer network 22 for an embodiment of the present invention that includes the Internet.Developer sites 24 each include one or more computers orother interface devices 28 to communicate overcomputer network 22. - Offering/
posting site 26 includes at least onecomputer server 30 for publishing one ormore descriptions 32 that each relate to a technical task, a few of which are schematically represented in FIG. 1 asdescriptions posting site 26 further includes an input (I/P)device 34 and an output (O/P)device 36 each operatively coupled toserver 30.Input device 34 may be a mouse, keyboard, trackball, voice recognition arrangement, a combination of these, or a different configuration as would occur those skilled in the art for receiving input from a server operator.Output device 36 can include a visual display, aural output arrangement, a printer, a combination of these, or a different configuration as would occur to those skilled in the art to provide output fromserver 30 to the server operator. - Offering/
posting site 26 also has access to one ormore sources 40 of chemical compounds that are schematically represented in FIG. 1. These chemical compounds are involved in the pharmaceutical development(s) to which one or more of thetechnical task descriptions 32 are directed. FIG. 1 also schematically depictschemical analysis equipment 50 such as a mass spectrometer, nuclear magnetic resonance spectrometer, infra-red spectrometer, ultra-violet spectrometer, gas chromatograph device, and/or one or more other chemical analysis devices that can be used to evaluate various chemically related technical tasks. Any ofdeveloper sites 24 may likewise include such equipment, but are not shown as such to preserve clarity. - For a form of
computer network 22 including the Internet,server 30 is preferably configured to provide a website upon whichdescriptions 32 are each posted as one or more web pages that can be accessed using a standard web browser program. For instance,devices 28 ofsites 24 could be used in conjunction with a web browser to access this form ofdescriptions 32. For web- and nonweb-based forms of the present invention,descriptions 32 can be made available to public in a totally unrestricted manner or restricted in part or in whole to selected individuals or groups by requiring entry of a password, decryption key, or the like. In another form of the present invention, access can be conditioned on acceptance of a confidentiality agreement by the inquiring party. Alternatively or additionally,descriptions 32 can be provided using a different media selected to reach potential process developers. Indeed, in one alternative embodiment, a computer network is not utilized. - FIGS. 2A and 2B depict system routine120 in flowchart form. Referring specifically to FIG. 2A, routine 120 begins in
stage 122 with the identification of a technical task for which it is suitable to offer a reward contingent on meeting predetermined acceptance requirement(s). In the case of a drug chemical application, various so-called “wet lab” tasks might include providing: (a) a more economical procedure to synthesize the target drug chemical and/or an intermediate chemical compound; (b) one or more samples of new chemical structures for pharmacological testing; (c) an analysis procedure for assaying a new substance; (d) a formulation of a new molecule entity as a new potential drug product; (e) a procedure for constructing a new chemical library; (f) a toxicity study of a new potential drug substance; (g) an identification of one or more metabolites; (h) one more pharmacological screens to show drug activity; (i) one or more surrogate markets for a disease state (lab test to predict clinical results); (j) an animal model for a disease; and/or (k) a clinical or blood plasma assay of a drug under test, just to name a few. - In addition or as an alternative to these wet lab examples, other laboratory-oriented technical tasks might include providing: (a) a new way of integrating/connecting laboratory equipment; (b) a new toxicology prediction procedure; (c) a statistical optimization protocol for one or more laboratory experiments; and/or (d) a drug efficacy prediction tool/procedure for Structure-Activity Relationships (SARs).
- Next, a task description, such as one of
descriptions 32, is published instage 124 bysite 26 usingserver 30.Description 32 preferably states the reward offer as a fixed monetary amount, a monetary amount that varies with indicated performance criteria, a portion of production sales, a combination of these, or in a different manner as would occur to those skilled in the art. Alternatively or additionally, an invitation to bid on the reward terms could be presented indescription 32.Description 32 can also set-forth the requirement or requirements from which to determine entitlement to the reward.Description 32 is made available viacomputer network 22 as one or more web pages. In other embodiments,description 32 can be alternatively or additionally provided by video, telefax, hard copy, verbal form, and/or with a different communication technique known to those skilled in the art besides a computer network. - After
stage 124, conditional 126 is encountered that tests whether there is a party interested indescription 32 as indicated by an email inquiry, or other form of communication. Such communication could be from anyprospective developer site 24 via the correspondingdevice 28, by telephone, telefax, or through different communication techniques as are known to those skilled in the art. If the test of conditional 126 is negative, route 120 loops back to conditional 126 until the test is affirmative. Once conditional 126 is affirmative, conditional 128 is encountered to test whether the interested party should be screened to determine suitability as a provider of the subject technical task. If a screen is applied, the affirmative branch of conditional 128 leads to stage 130 to perform the associated screening. Next, conditional 132 tests ifscreen 130 is passed by the interested party. If not, the interested party is informed of their ineligibility to participate instage 133, and routine 120 again loops back to conditional 126. - The screening process of routine120 can be directed to any number of different criteria before an acceptable party can become a participant. For example, this screening criteria may include verification that certain equipment and/or resources are available to the interested party. Optionally, credentials of the interested party can be investigated through
stage 130.Screening stage 130 can be used to conduct a procedure to qualify the interested party for continued participation. Alternatively or additionally,stage 130 can include establishment of a confidentiality agreement between the interested party and the entity represented bysite 26 to keep later revealed details confidential. In other embodiments, the screening provided byconditionals - If conditional128 is negative (no screen) or the conditional 132 is affirmative (screening of
stage 130 is passed), then routine 120 proceeds to stage 134. Instage 134, the interested party is provided a corresponding development kit that can include more detailed descriptive information, and/or a sample amount of one or more materials to which the corresponding technical task is directed. In the case of a pharmaceutical development application, a sample of a drug chemical associated with the development could be provided. In alternative embodiments, the provision of a development kit instage 134 can be optional or even absent. - One particular description example,
description 32 a, is further illustrated in FIG. 3. Fordescription 32 a, the corresponding technical task relates to synthesis of a schematically depictedchemical structure 132 in a manner acceptable for use as a human pharmaceutical with criteria including an overall cost goal and purity level as set forth in the first paragraph. The reward included indescription 32 a has a cash component of $75,000 and a royalty stream component contingent upon use of the synthesis process developed. The royalty is capped at a maximum of $2,000,000 per year. - Referring also to FIG. 2B, routine120 continues with
evaluation subroutine 140.Evaluation subroutine 140 starts with conditional 142 that tests whether results have been provided by a participating party in response to thecorresponding description 32 ofstage 124. For a pharmaceutical development application, these results can include data provided by designated laboratory procedures and/or equipment. More specifically, as depicted in FIG. 2B,process evaluation subroutine 140 is directed to evaluating performance of the technical task ofdescription 32 a. Fordescription 32 a, spectroscopic analysis of the output produced by the developed chemical synthesis procedure is to be submitted as part of the evaluation. Conditional 144 accordingly tests whether the spectral data indicates an acceptable process. If the spectrum is not acceptable, the unacceptable status is reported to the submitting participant instage 154 andsubroutine 140 loops back to conditional 142. - If the spectral results are acceptable, then subroutine140 proceeds to stage 146 to request a sample of a corresponding chemical compound produced by the participant as would be appropriate for the case of the new synthesis route development. For other types of technical tasks, a sample could be provided at the same time as spectral data is provided in
stage 142, or may not be included as part of the evaluation criteria at all. If a sample is submitted in response to stage 146, its acceptability is then evaluated in accordance with conditional 148 using some or all of the associatedchemical analysis equipment 50 as needed. In one embodiment relating to thedescription 32 a of FIG. 3, spectral analysis is conducted with this equipment to evaluate the sample, and/or one or more assays are performed. If the sample is unacceptable as tested by conditional 148, this negative evaluation is reported instage 154 andsubroutine 140 loops back to conditional 142. If the sample is acceptable, instage 150 an attempt is made to replicate the process, as applicable. - Conditional152 tests whether the replication is acceptable. If the replication is unacceptable,
subroutine 140 reports to the participant instage 154 and returns to conditional 142. If the submitted process is acceptably validated by the replication,subroutine 140 is exited and the reward is provided instage 160. Next, instage 162, the description is altered as appropriate to the circumstances. For example, it may be altered to indicate that the bounty has been claimed or otherwise modify the conditions under which participation is to continue. - In an alternative embodiment, the reward may not be provided in
stage 160 until an appropriate length of time passes, and/or until all known participants have been evaluated. In other cases, the description may unconditionally provide the reward to the first party to meet the acceptance criteria, while in others it may be the best process among several participants that exceed predefined, minimum requirements. Indeed, in still other embodiments, one or more participants that meet the minimum acceptance criteria can be rewarded. In fact, referring to the description of FIG. 3, the first five synthesis procedures that meet the target criteria are each provided a cash award of ten thousand dollars ($10,000), even if they are not used. It should be understood that routine 120 can be executed withsystem 20 for any of a number ofdifferent bounty descriptions 32 at the same time. - For different types of technical tasks bountied by routine120,
evaluation routine 140 can be suitably adjusted. For example, a given task may not produce a spectrum and/or sample - - - instead the evaluation is based on other quantitative and/or qualitative data as appropriate for the given task type. Furthermore, besides various pharmaceutical development applications, technical tasks directed to other developments/applications can be performed in accordance with the present invention. By way of nonlimiting example, technical tasks can be bountied for providing/developing: (a) an electrical circuit designed to a designated specification; (b) an optical lens designed to a designated specification; (c) a polymer having specified properties; (d) a software program having specified performance parameters; (e) a superconductor with specified properties; and/or (f) such other material, procedure, product, system, or assembly as would occur to those skilled in the art. - All publications and patent applications cited in this specification are herein incorporated by reference as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference. Further, any theory, mechanism of operation, proof, or findings stated herein is meant to further enhance understanding of the present invention, and is not intended to limit the present invention in any way to such theory, mechanism of operation, proof, or finding. While the invention has been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive in character, it being understood that only preferred embodiments have been shown and described and that all equivalents, changes, and modifications that come within the spirit of the inventions as defined by the following claims are desired to be protected.
Claims (35)
1. A method, comprising:
publishing a description of a technical task to a number of parties over a publicly accessible computer network, the technical task being directed to one or more of technical research, laboratory testing, product discovery, product development, or product manufacture, the description offering a reward contingent upon the performance of the technical task by any of the parties in accordance with a predefined requirement;
determining one of the parties performed the technical task in accordance with the predefined requirement; and
providing the reward to the one of the parties.
2. The method of claim 1 , wherein the technical task includes providing at least one of the group consisting of: a synthesis procedure for a specified drug chemical, a drug chemical, an assay for a specified drug chemical, a drug formulation, a library of different chemicals relating to drugs, a metabolite identification, a pharmacological screen to show activity of a drug, a surrogate marker for a disease state, and an animal model for a specified disease.
3. The method of claim 1 , wherein the technical task includes developing at least one of the group consisting of: a laboratory equipment design, a toxicology prediction procedure, a statistical optimization of lab experiments, and a drug efficacy prediction procedure.
4. The method of claim 1 , wherein the technical task includes developing at least one of the group consisting of: an electrical circuit, an optical lens, and a polymer with one or more specified properties.
5. The method of claim 1 , wherein the technical task relates to a drug chemical.
6. The method of claim 5 , wherein the technical task includes establishing a procedure for synthesizing the drug chemical.
7. The method of claim 5 , wherein the drug chemical is an intermediate compound for producing a pharmaceutical.
8. The method of claim 5 , further comprising providing a sample of the drug chemical to each of several of the parties.
9. The method of claim 5 , wherein the one of the parties provides a compound sample for said evaluating.
10. The method of claim 9 , wherein said evaluating includes performing an assay of the compound sample.
11. The method of claim 9 , wherein said evaluating includes performing a spectroscopic analysis of the compound sample.
12. The method of claim 1 , wherein the description is provided in the form of one or more web pages.
13. A method, comprising:
publishing a description including a reward offer for acceptable performance of a technical task involving a chemical compound;
communicating with each of a number of parties responding to the description;
providing an amount of the chemical compound to each the number of parties;
evaluating performance of the technical task by one of the parties; and
rewarding the one of the parties in accordance with the reward offer.
14. The method of claim 13 , further comprising providing spectroscopic information relating to the chemical compound to one or more of the parties.
15. The method of claim 13 , wherein the chemical compound includes a drug chemical.
16. The method of claim 13 , wherein the technical task includes providing at least one of: a synthesis procedure for the chemical compound, an assay for the chemical compound, a drug formulation including the chemical compound, and a pharmacological screen to show activity of the chemical compound as a drug.
17. The method of claim 13 , wherein said providing includes:
posting the offer over a computer network including the internet; and
presenting the offer in the form of one or more web pages publicly accessible on the world wide web.
18. The method of claim 13 , wherein the one of the parties produces a compound sample for said evaluating.
19. The method of claim 18 , wherein said evaluating includes performing an assay of the compound sample.
20. The method of claim 18 , wherein said evaluating includes performing a spectroscopic analysis of the compound sample.
21. A method to promote drug development, comprising:
providing an offer over a computer network to reward any of several parties for development of an acceptable synthesis procedure for a drug chemical;
for at least one of the parties, evaluating a submission relating to a procedure developed in response to the offer;
determining one of the parties developed the acceptable synthesis procedure; and
rewarding the one of the parties.
22. The method of claim 21 , further comprising providing spectroscopic information relating to the drug chemical to each of the parties.
23. The method of claim 21 , further comprising providing an amount of the drug chemical to each of the parties.
24. The method of claim 21 , wherein the drug chemical is an intermediate compound for producing a pharmaceutical.
25. The method of claim 21 , wherein the computer network includes the internet and said providing includes presenting the offer in the form of one or more web pages publicly accessible on the world wide web.
26. The method of claim 21 , wherein the one of the parties produces a compound sample for said evaluating and said evaluating includes testing the compound sample.
27. The method of claim 26 , wherein said testing includes spectroscopically analyzing the compound sample.
28. The method of claim 21 , wherein said evaluating includes executing the process in accordance with the submission of the one of the parties.
29. A system, comprising:
a computer network;
an input device;
a computer server coupled to said network and said input device, said computer server including logic to present a publicly accessible description over said computer network including a reward offer for acceptable performance of a technical task associated with a designated chemical compound;
chemical analysis equipment to evaluate a compound sample submitted by one or more parties in response to the reward offer; and
wherein said computer server is responsive to input from said input device to alter the description after the acceptable performance of the technical task is determined through an evaluation performed with said chemical analysis equipment.
30. The system of claim 29 , further comprising a chemical compound source to provide an amount of the designated chemical compound to one or more of the parties.
31. The system of claim 29 , wherein said computer network includes the internet, said computer server is programmed to provide the description in the form of one or more web pages, and the one or more parties each correspond to a different interface device coupled to said computer network.
32. The system of claim 29 , wherein said chemical analysis equipment includes a spectroscopic analyzer.
33. The system of claim 29 , wherein the chemical compound is an intermediate for producing a pharmaceutical.
34. The system of claim 29 , wherein the technical task includes providing at least one of: a synthesis procedure for the chemical compound, an assay for the chemical compound, a drug formulation including the chemical compound, and a pharmacological screen to show activity of the chemical compound as a drug.
35. A system comprising:
a computer network communicatively coupling a number of interface devices together;
means for publishing a description accessible through any of said interface devices over said computer network, the description including a reward offer for performance of a technical task in accordance with one or more specified criteria;
means for evaluating the performance of the technical task by one or more of the parties in response to the reward offer; and
means for rewarding one of the parties for acceptably performing the technical task based on said evaluating means.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/415,760 US20040054582A1 (en) | 2001-11-06 | 2001-11-06 | Technical task performance techniques |
US12/660,690 US20100293040A1 (en) | 2000-11-20 | 2010-03-01 | Technical task performance techniques |
US13/627,182 US20130132168A1 (en) | 2000-11-20 | 2012-09-26 | Technical Task Performance Techniques |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2001/027800 WO2002043300A2 (en) | 2000-11-20 | 2001-11-06 | Technical task performance techniques |
US10/415,760 US20040054582A1 (en) | 2001-11-06 | 2001-11-06 | Technical task performance techniques |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/660,690 Continuation US20100293040A1 (en) | 2000-11-20 | 2010-03-01 | Technical task performance techniques |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040054582A1 true US20040054582A1 (en) | 2004-03-18 |
Family
ID=31994294
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/415,760 Abandoned US20040054582A1 (en) | 2000-11-20 | 2001-11-06 | Technical task performance techniques |
US12/660,690 Abandoned US20100293040A1 (en) | 2000-11-20 | 2010-03-01 | Technical task performance techniques |
US13/627,182 Abandoned US20130132168A1 (en) | 2000-11-20 | 2012-09-26 | Technical Task Performance Techniques |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/660,690 Abandoned US20100293040A1 (en) | 2000-11-20 | 2010-03-01 | Technical task performance techniques |
US13/627,182 Abandoned US20130132168A1 (en) | 2000-11-20 | 2012-09-26 | Technical Task Performance Techniques |
Country Status (1)
Country | Link |
---|---|
US (3) | US20040054582A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100174603A1 (en) * | 2008-10-14 | 2010-07-08 | Robert Hughes | System and Method for Advertising Placement and/or Web Site Optimization |
Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US21915A (en) * | 1858-10-26 | Apparatus fob | ||
US51913A (en) * | 1866-01-09 | Improved tank for preparing peat | ||
US4870590A (en) * | 1987-01-30 | 1989-09-26 | Yokogawa Electric Corporation | Manufacturing line control system |
US5359508A (en) * | 1993-05-21 | 1994-10-25 | Rossides Michael T | Data collection and retrieval system for registering charges and royalties to users |
US5734883A (en) * | 1995-04-27 | 1998-03-31 | Michael Umen & Co., Inc. | Drug document production system |
US5987474A (en) * | 1995-08-04 | 1999-11-16 | Aircraft Technical Publishers | Computer aided maintenance and repair information system for equipment subject to regulatory compliance |
US6064978A (en) * | 1997-06-24 | 2000-05-16 | Experts Exchange, Inc. | Question and answer system using computer networks |
US20010021915A1 (en) * | 1999-12-29 | 2001-09-13 | Beenz . Com Ireland Ltd. | Compensation driven network based exchange system and method |
US20010032092A1 (en) * | 2000-02-07 | 2001-10-18 | James Calver | Small business web-based portal method and system |
US20010049084A1 (en) * | 2000-05-30 | 2001-12-06 | Mitry Darryl Joseph | Interactive rewards-based pedagogical system using an engine of artificial intelligence |
US20010051913A1 (en) * | 2000-06-07 | 2001-12-13 | Avinash Vashistha | Method and system for outsourcing information technology projects and services |
US20020052862A1 (en) * | 2000-07-28 | 2002-05-02 | Powerway, Inc. | Method and system for supply chain product and process development collaboration |
US20020198727A1 (en) * | 2001-06-22 | 2002-12-26 | International Business Machines Corporation | Method and system using an enterprise framework |
US20030055702A1 (en) * | 2001-09-20 | 2003-03-20 | International Business Machines Corporation | System and method for estimating and planning website development |
US20040143811A1 (en) * | 2002-08-30 | 2004-07-22 | Elke Kaelicke | Development processes representation and management |
US6797284B2 (en) * | 2000-12-12 | 2004-09-28 | Ursula Mariah Rothlin | Phytopharmaceutical food products or integrators |
US20050071348A1 (en) * | 2003-07-18 | 2005-03-31 | Karolin Laicher | Computing systems that capture cost information for total cost of ownership analyses |
US20050198047A1 (en) * | 2004-03-04 | 2005-09-08 | Patrick Garcia | Method of managing advanced engineering activities |
-
2001
- 2001-11-06 US US10/415,760 patent/US20040054582A1/en not_active Abandoned
-
2010
- 2010-03-01 US US12/660,690 patent/US20100293040A1/en not_active Abandoned
-
2012
- 2012-09-26 US US13/627,182 patent/US20130132168A1/en not_active Abandoned
Patent Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US21915A (en) * | 1858-10-26 | Apparatus fob | ||
US51913A (en) * | 1866-01-09 | Improved tank for preparing peat | ||
US4870590A (en) * | 1987-01-30 | 1989-09-26 | Yokogawa Electric Corporation | Manufacturing line control system |
US5359508A (en) * | 1993-05-21 | 1994-10-25 | Rossides Michael T | Data collection and retrieval system for registering charges and royalties to users |
US5734883A (en) * | 1995-04-27 | 1998-03-31 | Michael Umen & Co., Inc. | Drug document production system |
US5987474A (en) * | 1995-08-04 | 1999-11-16 | Aircraft Technical Publishers | Computer aided maintenance and repair information system for equipment subject to regulatory compliance |
US6064978A (en) * | 1997-06-24 | 2000-05-16 | Experts Exchange, Inc. | Question and answer system using computer networks |
US20010021915A1 (en) * | 1999-12-29 | 2001-09-13 | Beenz . Com Ireland Ltd. | Compensation driven network based exchange system and method |
US20010032092A1 (en) * | 2000-02-07 | 2001-10-18 | James Calver | Small business web-based portal method and system |
US20010049084A1 (en) * | 2000-05-30 | 2001-12-06 | Mitry Darryl Joseph | Interactive rewards-based pedagogical system using an engine of artificial intelligence |
US20010051913A1 (en) * | 2000-06-07 | 2001-12-13 | Avinash Vashistha | Method and system for outsourcing information technology projects and services |
US20020052862A1 (en) * | 2000-07-28 | 2002-05-02 | Powerway, Inc. | Method and system for supply chain product and process development collaboration |
US6797284B2 (en) * | 2000-12-12 | 2004-09-28 | Ursula Mariah Rothlin | Phytopharmaceutical food products or integrators |
US20020198727A1 (en) * | 2001-06-22 | 2002-12-26 | International Business Machines Corporation | Method and system using an enterprise framework |
US20030055702A1 (en) * | 2001-09-20 | 2003-03-20 | International Business Machines Corporation | System and method for estimating and planning website development |
US20040143811A1 (en) * | 2002-08-30 | 2004-07-22 | Elke Kaelicke | Development processes representation and management |
US20050071348A1 (en) * | 2003-07-18 | 2005-03-31 | Karolin Laicher | Computing systems that capture cost information for total cost of ownership analyses |
US20050198047A1 (en) * | 2004-03-04 | 2005-09-08 | Patrick Garcia | Method of managing advanced engineering activities |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100174603A1 (en) * | 2008-10-14 | 2010-07-08 | Robert Hughes | System and Method for Advertising Placement and/or Web Site Optimization |
Also Published As
Publication number | Publication date |
---|---|
US20100293040A1 (en) | 2010-11-18 |
US20130132168A1 (en) | 2013-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Van Der Zalm et al. | A framework for establishing scientific confidence in new approach methodologies | |
Brown | Managing challenges in sustaining business excellence | |
Viana Thompson et al. | The business value of e‐government for small firms | |
US20070220479A1 (en) | Systems and methods for software development | |
Kopczyńska et al. | An empirical study on catalog of non-functional requirement templates: Usefulness and maintenance issues | |
Atikbay et al. | Effects of human resources management practices and organizational justice perceptions on organizational cynicism: A research on municipalities in a developing country | |
Eisty et al. | Developers perception of peer code review in research software development | |
Zhou | Regulated bioanalytical laboratories: technical and regulatory aspects from global perspectives | |
Schuir et al. | Understanding the augmented and virtual reality business ecosystem: an e 3-value approach | |
US20130132168A1 (en) | Technical Task Performance Techniques | |
Patanakul et al. | Exploring the concept of value creation in program planning and systems engineering processes | |
WO2002043300A2 (en) | Technical task performance techniques | |
US7603324B2 (en) | Operationalizing a learning solution | |
Guidini Gonçalves et al. | HCI in practice: An empirical study with software process capability maturity model consultants in Brazil | |
Darling et al. | Sham project compliance behaviour: Necessarily masking the reality of project work from senior management | |
Mielke et al. | A metric for evaluating a transformation of subscription-based journals into open-access journals | |
AL et al. | Developing predictive models for acute oral systemic toxicity: lessons learned from a global collaboration | |
Ismail et al. | Computerized accounting system at the MARA state offices | |
Goswami et al. | A review on application of quality by design concept to analytical techniques | |
Urbach et al. | Industry-specificity of employee portal success: a multi-group comparison | |
US20060112030A1 (en) | On demand learning | |
Riedl | On the replication of positivist case study research | |
Morana et al. | Designing Process Guidance Systems the Case of IT Service Management | |
Powell et al. | Development, commercialization, and diffusion of enabling technologies: Progress report | |
Van Looy et al. | A theoretical lens on maturity models as boundary objects |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: INNOCENTIVE, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ELI LILLY AND COMPANY;REEL/FRAME:017365/0190 Effective date: 20060224 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |